Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Reduction of cerebral blood flow in community-based adults with subclinical cerebrovascular atherosclerosis: A 3.0T magnetic resonance imaging study
First author：Hualu Han,Runhua Zhang
Corresponding author：Gaifen Liu,Xihai Zhao
essential_information
- Person in charge：Hualu Han,Runhua Zhang
- Data Sources： CAMERA
- Number of papers：OTHERS20190066
- Published time：2019-04-01
2019-04-01
Published articles
Journal：NeuroImage
Publication type: Original Contributions
IF(IF): 6.556
PMID: 30553041 Link To Pubmed Full text Download
Background And Purpose
Reduction in cerebral blood flow (CBF), one of the major metrics for cerebral perfusion, is associated with many brain disorders. Therefore, early characterization of CBF prior to occurrence of symptoms is essential for prevention of cerebral ischemic events. We hypothesized that large artery atherosclerosis might be a potential indicator for decline in cerebral perfusion. The aim of this study was to investigate the relationship between large artery atherosclerosis and CBF in asymptomatic adults.
Method
A total of 134 asymptomatic subjects (mean age, 56.2 12.8 years; 54 males) were recruited and underwent magnetic resonance (MR) imaging for brain and intracranial and extracranial carotid arteries. Presence or absence of cerebrovascular atherosclerosis was determined on MR vessel wall images. The CBF was measured with pseudo-continuous arterial spin labeling (pCASL) imaging.
Conclusion
In conclusion, presence of cerebrovascular atherosclerosis is independently associated with reduction in CBF measured by pCASL in asymptomatic adults, suggesting that cerebrovascular large artery atherosclerosis might be an effective indicator for impairment of cerebral microcirculation hemodynamics.
Main results
The CBF values in internal carotid artery (ICA) (37.2 5.8 vs. 39.0 4.9 ml/100 g/min, P ¼ 0.049) and vertebrobasilar artery (VA-BA) territories (42.0 6.8 vs. 44.8 7.0 ml/100 g/min, P ¼ 0.023) were significantly reduced in subjects with cerebrovascular plaque compared to those without. Presence of cerebrovascular plaque was significantly associated with CBF of VA-BA territory before (odds ratio, 2.89; 95% confidence interval, 1.37–6.08; P ¼ 0.005) and after adjusted for confounding factors including age, gender, body-mass-index, diabetes, systolic blood pressure, hyperlipidemia and history of cardiovascular disease (odds ratio, 2.76; 95% confidence interval, 1.18–6.46; P ¼ 0.019).